Ligand Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world.

CEO

Todd Christopher Davis

CEOTodd Christopher Davis

Employees

Employees47

Headquarters

Jupiter, Florida

HeadquartersJupiter, Florida

Founded

1987

Founded1987

Employees

Employees47

LGND Key Statistics

Market cap

5.87B

Market cap5.87B

Price-Earnings ratio

31.50

Price-Earnings ratio31.50

Dividend yield

—

Dividend yield—

Average volume

281.88K

Average volume281.88K

High today

$295.19

High today$295.19

Low today

$287.36

Low today$287.36

Open price

$287.61

Open price$287.61

Volume

197.03K

Volume197.03K

52 Week high

$326.63

52 Week high$326.63

52 Week low

$149.51

52 Week low$149.51

Stock Snapshot

With a market cap of 5.87B, Ligand Pharmaceuticals(LGND) trades at $294.60. The stock has a price-to-earnings ratio of 31.50.

On 2026-08-16, Ligand Pharmaceuticals(LGND) stock moved within a range of $287.36 to $295.19. With shares now at $294.60, the stock is trading +2.5% above its intraday low and -0.2% below the session's peak.

Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 197.03K, versus its average volume of 281.88K.

The stock's 52-week range extends from a low of $149.51 to a high of $326.63.

LGND News

TipRanks 2d

Major Insider Move at Ligand Pharma Raises Investor Eyebrows

New insider activity at Ligand Pharma ( (LGND) ) has taken place on August 14, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premiu...

Investing.com 2d

Ligand Pharmaceuticals CFO Octavio Espinoza sells $9.2m in shares - Investing.com

...

The Motley Fool 4d

Ligand Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Melanie Herman Chief Executive Officer - T...

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

More LGND News

Simply Wall St 5d

Ligand Pharmaceuticals Stock Looks Undervalued On Cash Flow While Earnings Look Overvalued

Ligand Pharmaceuticals stock has delivered a very strong 327.2% return over the past three years, while recent valuation checks point in different directions. A...

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Alibaba

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.